DR. BRIAN K ROBERTS, M.D.
Osteopathic Medicine at 45 St, Oakland, CA
License number
California A80557
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
1250 45Th St STE 355, Oakland, CA 94608
156 Middlefield Rd, Palo Alto, CA 94301
156 Middlefield Rd, Palo Alto, CA 94301
Phone
(510) 596-8988
(510) 596-8956 (Fax)
(510) 596-8956 (Fax)
Personal information
See more information about BRIAN K ROBERTS at radaris.comName
Address
Phone
456 Wayne Ave, Oakland, CA 94606
470 W Workman St, Covina, CA 91723
43 Sea Terrace St, Dana Point, CA 92629
430 S Orange Ave, Azusa, CA 91702
48 61St Pl, Long Beach, CA 90803
Organization information
See more information about BRIAN K ROBERTS at bizstanding.comBrian K Roberts MD
300 Pasteur Dr #S101, Stanford, CA 94305
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Internal Medicine Physicians & Surgeons
Phone:
(650) 723-4000 (Phone)
Professional information
See more information about BRIAN K ROBERTS at trustoria.com
Method For Treating Hyperuricemia In Patients With Gout Using Halofenate Or Halofenic Acid And An Anti-Inflammatory Agent
Method For Treating Hyperuricemia In Patients With Gout Using Halofenate Or Halofenic Acid And An Anti-Inflammatory Agent
US Patent:
2013027, Oct 17, 2013
Filed:
Apr 12, 2013
Appl. No.:
13/862262
Inventors:
Brian Edward Lavan - San Francisco CA, US
Brian K. Roberts - Palo Alto CA, US
Charles A. McWherter - Oakland CA, US
Brian K. Roberts - Palo Alto CA, US
Charles A. McWherter - Oakland CA, US
International Classification:
A61K 31/216, A61K 31/165
US Classification:
514534
Abstract:
Disclosed herein are pharmaceutical compositions, methods and kits for lowering the serum uric acid level of a subject and for the treatment of a condition associated with elevated serum uric acid levels comprising administering a composition comprising a urate-lowering agent and an anti-inflammatory agent. In some aspects the urate-lowering agent is (−)-halofenate, (−)-halofenic acid, or a pharmaceutically acceptable salts thereof. In some aspects the second agent is an anti-inflammatory agent, or a pharmaceutically acceptable salt thereof.
Brian Kenneth Roberts, Emeryville CA
Brian Kenneth Roberts, Emeryville CA
Specialties:
Internist
Address:
1250 45Th St, Emeryville, CA 94608
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
Georgetown University, School of Medicine - Doctor of Medicine
Georgetown University - Master of Science in Electrical Engineering
Stanford Hospital & Clinics - Fellowship - Endocrinology
Stanford Hospital & Clinics - Residency - Internal Medicine
Stanford Hospital & Clinics - Internship - Internal Medicine
Georgetown University - Master of Science in Electrical Engineering
Stanford Hospital & Clinics - Fellowship - Endocrinology
Stanford Hospital & Clinics - Residency - Internal Medicine
Stanford Hospital & Clinics - Internship - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Methods For Treating Hyperuricemia In Patients With Gout Using Halofenate Or Halogenic Acid And A Second Urate-Lowering Agent
Methods For Treating Hyperuricemia In Patients With Gout Using Halofenate Or Halogenic Acid And A Second Urate-Lowering Agent
US Patent:
2013017, Jul 4, 2013
Filed:
Nov 2, 2012
Appl. No.:
13/668164
Inventors:
Brian K. Roberts - Palo Alto CA, US
Gopal Chandra Saha - Dublin CA, US
Brian Edward Lavan - San Francisco CA, US
Charles A. McWherter - Oakland CA, US
Gopal Chandra Saha - Dublin CA, US
Brian Edward Lavan - San Francisco CA, US
Charles A. McWherter - Oakland CA, US
International Classification:
A61K 31/519, A61K 31/426, A61K 45/06, A61K 31/216
US Classification:
5142621, 514534, 514365
Abstract:
Disclosed herein are pharmaceutical compositions, methods and kits for lowering the serum uric acid level of a subject and for the treatment of a condition associated with elevated serum uric acid levels comprising administering a composition comprising a first urate-lowering agent and a second urate-lowering agent. In some aspects the first urate-lowering agent is (−)-halofenate, (−)-halofenic acid, or a pharmaceutically acceptable salts thereof. In some aspects the second urate-lowering agent is an inhibitor of uric acid production, a uricosuric agent, a uricase, or a pharmaceutically acceptable salt thereof.
Dr. Brian K Roberts, Emeryville CA - MD (Doctor of Medicine)
Dr. Brian K Roberts, Emeryville CA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Age:
49
Address:
1250 45Th St, Emeryville 94608
(510) 596-8988 (Phone)
2333 Buchanan St, San Francisco 94115
(415) 600-6000 (Phone)
(510) 596-8988 (Phone)
2333 Buchanan St, San Francisco 94115
(415) 600-6000 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2006, Internal Medicine, 2004
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
1250 45Th St, Emeryville 94608
2333 Buchanan St, San Francisco 94115
California Pacific Medical Center - Pacific
2333 Buchanan St, San Francisco 94115
2333 Buchanan St, San Francisco 94115
California Pacific Medical Center - Pacific
2333 Buchanan St, San Francisco 94115
Education:
Medical School
Georgetown University School Of Medicine
Graduated: 2001
Stanford University Medical Center
Graduated: 2002
Graduated: 2004
Graduated: 2007
Georgetown University School Of Medicine
Graduated: 2001
Stanford University Medical Center
Graduated: 2002
Graduated: 2004
Graduated: 2007
Brian Kenneth Roberts, Emeryville CA
Brian Kenneth Roberts, Emeryville CA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Hospitalist
Work:
IPC Hospitalist Company
1250 45Th St, Emeryville, CA 94608
1250 45Th St, Emeryville, CA 94608
Education:
Georgetown University (2001)
Methods For Treating Gout In Patients Subpopulations
Methods For Treating Gout In Patients Subpopulations
US Patent:
2013030, Nov 14, 2013
Filed:
Nov 2, 2012
Appl. No.:
13/668024
Inventors:
Gopal Chandra Saha - Dublin CA, US
Brian K. Roberts - Palo Alto CA, US
Brian Edward Lavan - San Francisco CA, US
Charles A. McWherter - Oakland CA, US
Brian K. Roberts - Palo Alto CA, US
Brian Edward Lavan - San Francisco CA, US
Charles A. McWherter - Oakland CA, US
International Classification:
A61K 31/216, A61K 45/06
US Classification:
424 944, 514534, 514365, 514171, 514383, 514 97
Abstract:
The present application discloses a method of lowering serum uric acid level in a subject with impaired renal function, comprising administering to the subject a compound of Formula (I), as disclosed herein.